Skip to content

Tag Archives: findings

Study Identifies Genetic Variant That Can Lead To Severe Impulsivity

A multinational research team led by scientists at the National Institutes of Health has found that a genetic variant of a brain receptor molecule may contribute to violently impulsive behavior when people who carry it are under the influence of alcohol. A report of the findings, which include human genetic analyses and gene knockout studies in animals, appears in the Dec. 23 issue of Nature…

Examining gender differences in substance use and age of first use among rural Appalachian drug users in Kentucky.

Conclusion: Findings suggest more men report the use of alcohol and “street” drugs, including heroin, crack cocaine, methamphetamine, marijuana, and hallucinogens. Furthermore, males report the use of alcohol, marijuana, and hallucinogens at a significantly younger age. Scientific Significance: Understanding gender differences in substance use as well as other differences among individuals living in rural Appalachia presents important opportunities to incorporate this knowledge into substance abuse early intervention, prevention, and treatment efforts.

Research Study Validates Technology For Abuse Deterrent Prescription Drugs

Pisgah Labs announced the findings from a proof of concept study confirming Pisgah’s technology imparts abuse deterrence to commonly abused prescription drugs, particularly narcotics…

“It’s not rocket science, what I doâ€�: Self-directed harm reduction strategies among drug using ethno-racially diverse gay and bisexual…

Conclusions: We discuss our findings in relation to prior research and to critical theory. We suggest that drug users’ awareness of possible harm, and their personal investment in harm reduction, constitute a viable platform from which community-based and public health organisations may promote and strengthen harm reduction among gay and bisexual men from ethno-racially diverse backgrounds

A Statement from GlaxoSmithKline Consumer Healthcare on FDA Regulation of Smokeless Tobacco Products

GlaxoSmithKline (GSK) Consumer Healthcare, a leader in helping smokers quit and the marketer of nicotine replacement therapy (NRT) products, including Nicorette(R) and NicoDerm(R) CQ(R), supports the findings of the American Heart Association (AHA) policy statement regarding smokeless tobacco products.(1) GSK Consumer Healthcare agrees that these products should not be used as an alternative to cigarettes or for smoking cessation due to the potential negative health consequences and their impact on smoking behavior.

DrugScope Responds To New Official Data On Drug Use Trends

DrugScope has responded to the publication of two sets of official statistics detailing the prevalence of drug use among adults and young people. The Home Office’s Drug misuse declared: Findings from the British Crime Survey 2009/10 presents estimates of the prevalence of illegal drug use among 16 to 59 year olds in England and Wales [1]…

Electronic Cigarettes Not a Safe Alternative to Conventional Cigs

Although electronic cigarettes have recently been marketed as a safer alternative to traditional smokes, a new analysis of 19 types of the e-cigarettes revealed that they contain toxic chemicals.

Genes Influence Development Of Gambling Disorders In Men And Women Suggests New Study

From studying Australian twins, new research says that genetic factors appear to influence the development of gambling disorders in both men and women. These were the findings of Dr Wendy S…

Best evidence yet for web-based alcohol self-help

The UK drug and alcohol research bank Findings has released the bulletin 'Translating effective web-based self-help for problem drinking into the real world' . According to the Findings bulletin: 'The researchers concluded that the featured study had shown that the benefits established by the randomised controlled trial would be sustained when the intervention was made routinely and generally available to the public

BME National Alcohol Workshop 6th July 2010

The Alcohol Improvement Programme (AIP) will be holding a national workshop on the 6th July to examine the needs of Black and Minority Ethnic (BME) groups in relation to alcohol-harm.